These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 13764142)

  • 21. Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin.
    Snead OC; Bearden LJ
    Science; 1980 Nov; 210(4473):1031-3. PubMed ID: 6254150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [TREATMENT BY ETHOSUXIMIDE OF PETIT MAL EPILEPSY IN CHILDREN].
    CHASSAGNE P; GEORGES-JANET L; MARY F
    Therapie; 1964; 19():1617-35. PubMed ID: 14244482
    [No Abstract]   [Full Text] [Related]  

  • 23. [THERAPEUTIC EXPERIENCES WITH A SUCCINIMIDE DERIVATIVE IN THE FORM OF A SYRUP].
    SPIEL W; ZAPOTOCZKY H
    Wien Med Wochenschr; 1963 Sep; 113():725-6. PubMed ID: 14091756
    [No Abstract]   [Full Text] [Related]  

  • 24. CERTAIN BASIC CONCEPTS CONCERNING THE TREATMENT OF THE EPILEPSIES.
    GASTAUT H
    Br J Clin Pract; 1964 Aug; 18():463-8. PubMed ID: 14206257
    [No Abstract]   [Full Text] [Related]  

  • 25. Ethosuximide in the treatment of epilepsy. Preliminary report.
    LIVINGSTON S; PAULI L; NAJMABADI A
    JAMA; 1962 Jun; 180():822-5. PubMed ID: 14465991
    [No Abstract]   [Full Text] [Related]  

  • 26. Ethosuximide in the treatment of epilepsy.
    GOLDENSOHN ES; HARDIE J; BOREA ED
    JAMA; 1962 Jun; 180():840-2. PubMed ID: 13899742
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of petit mal epilepsy with 3-ethyl-3-methylsuccinimide (Zarontin, Suxinutin)].
    SZULC-KUBERSKA J
    Pol Tyg Lek; 1963 Jan; 18():19-21. PubMed ID: 13980031
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethosuximide and bicuculline inhibition in petit mal epilepsy.
    Englander RN; Johnson RN; Hanna GR
    Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):265-75. PubMed ID: 99676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ERYTHEMA EXSUDATIVUM MULTIFORME MAJUS (STEVENS-JOHNSON SYNDROME) DUE TO SUXINUTIN HYPERSENSITIVITY].
    MUELLER K
    Z Kinderheilkd; 1963 Dec; 88():548-63. PubMed ID: 14106514
    [No Abstract]   [Full Text] [Related]  

  • 30. CURRENT CONCEPTS IN THERAPY: TREATMENT OF SEIZURE DISORDERS (EPILEPSY). (CONCLUDED FROM DECEMBER 12).
    SCHOLL ML
    N Engl J Med; 1963 Dec; 269():1421-3 CONCL. PubMed ID: 14065485
    [No Abstract]   [Full Text] [Related]  

  • 31. TREATMENT OF PETIT MAL WITH ETHOSUXIMIDE.
    O'DONOHOE NV
    Dev Med Child Neurol; 1964 Oct; 6():498-501. PubMed ID: 14215228
    [No Abstract]   [Full Text] [Related]  

  • 32. A new drug for petit mal epilepsy.
    ZIMMERMAN FT; BURGEMEISTER BB
    Neurology; 1958 Oct; 8(10):769-75. PubMed ID: 13590384
    [No Abstract]   [Full Text] [Related]  

  • 33. Prenderol: a new drug used with retarders in petit mal epilepsy.
    PERLSTEIN MA
    Neurology; 1953 Oct; 3(10):744-51. PubMed ID: 13099463
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ethosuximide in treatment of petit mal epilepsy].
    Kiehi Y; Ando J
    No To Shinkei; 1965 Aug; 17(8):831-40. PubMed ID: 4957471
    [No Abstract]   [Full Text] [Related]  

  • 35. [On the therapy of recurrent epileptic absences. (Retropulsive petit mal, pyknolepsy)].
    GROH C
    Wien Med Wochenschr; 1962 May; 112():413-4. PubMed ID: 13902097
    [No Abstract]   [Full Text] [Related]  

  • 36. [Practical treatment of petit mal epilepsy].
    DREYER R
    Nervenarzt; 1955 Jun; 26(6):225-8. PubMed ID: 13244753
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of milontin in the control of petit mal epilepsy.
    CARTER CH
    Neurology; 1954 Dec; 4(12):935-7. PubMed ID: 14356342
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of N-methyl-a, a-methylphenyl succinimide in the treatment of petit mal epilepsy.
    ZIMMERMAN FT
    N Y State J Med; 1956 May; 56(9):1460-5. PubMed ID: 13309721
    [No Abstract]   [Full Text] [Related]  

  • 39. Drugs used in treatment of patients with petit mal epilepsy; a serial evaluation of new and standard drugs with alternate placebo baselines in identical cases.
    ZIMMERMAN FT; BURGEMEISTER BB
    J Am Med Assoc; 1955 Apr; 157(14):1194-8. PubMed ID: 14353658
    [No Abstract]   [Full Text] [Related]  

  • 40. Use of N-methyl-alpha, alpha-methylphenylsuccinimide in treatment of petit mal epilepsy.
    ZIMMERMAN FT; BURGEMEISTER BB
    AMA Arch Neurol Psychiatry; 1954 Dec; 72(6):720-5. PubMed ID: 13206491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.